JO2570B1 - Composition for Sustained Drug Release and the use thereof - Google Patents

Composition for Sustained Drug Release and the use thereof

Info

Publication number
JO2570B1
JO2570B1 JO200614A JOP20060014A JO2570B1 JO 2570 B1 JO2570 B1 JO 2570B1 JO 200614 A JO200614 A JO 200614A JO P20060014 A JOP20060014 A JO P20060014A JO 2570 B1 JO2570 B1 JO 2570B1
Authority
JO
Jordan
Prior art keywords
drug release
composition
sustained drug
chitosan
sustained
Prior art date
Application number
JO200614A
Other languages
Arabic (ar)
Inventor
الريماوي مياس
بدوان عدنان
عبد القادر محمد مرشد
Original Assignee
الشركة الأردنية لأنتاج الأدوية
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by الشركة الأردنية لأنتاج الأدوية filed Critical الشركة الأردنية لأنتاج الأدوية
Priority to JO200614A priority Critical patent/JO2570B1/en
Application granted granted Critical
Publication of JO2570B1 publication Critical patent/JO2570B1/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

The present invention relates to a compositions for sustained drug release, comprising chitosan dissolved in a solvent having a pH of below about 4.0, wherein the chitosan is selected from the group of chitosans precipitating in a pH range of between about 3.0 and about 7,5; and at least one drug compound soluble in the above chitosan solution
JO200614A 2006-01-18 2006-01-18 Composition for Sustained Drug Release and the use thereof JO2570B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JO200614A JO2570B1 (en) 2006-01-18 2006-01-18 Composition for Sustained Drug Release and the use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JO200614A JO2570B1 (en) 2006-01-18 2006-01-18 Composition for Sustained Drug Release and the use thereof

Publications (1)

Publication Number Publication Date
JO2570B1 true JO2570B1 (en) 2010-09-05

Family

ID=48045842

Family Applications (1)

Application Number Title Priority Date Filing Date
JO200614A JO2570B1 (en) 2006-01-18 2006-01-18 Composition for Sustained Drug Release and the use thereof

Country Status (1)

Country Link
JO (1) JO2570B1 (en)

Similar Documents

Publication Publication Date Title
WO2007140439A3 (en) Compounds as cannabinoid receptor ligands and uses thereof
WO2007140385A3 (en) Thiazole compounds as cannabinoid receptor ligands and uses thereof
WO2008030744A3 (en) Inhibitors of c-met and uses thereof
WO2006114520A3 (en) Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof
MX2011012122A (en) Thiophene derivatives.
WO2010136474A3 (en) Substituted aminobutyric derivatives as neprilysin inhibitors
WO2009142571A8 (en) Phenyl and benzodioxinyl substituted indazoles derivatives
WO2007061360A3 (en) Novel 3-bicyclocarbonylaminopyridine-2-carboxamides or 3-bicyclocarbonylaminopyrazine-2-carboxamides
UA95644C2 (en) Pyridizinone derivative, pharmaceutical composition and treatment method
MY154464A (en) Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof
MX2008014101A (en) 4,5-diphenyl-pyrimidinyl-amino substituted carboxylic acids, method for the production and use thereof as medicaments.
WO2008062376A3 (en) New process for the preparation of 2-imino-thiazolidin-4-one derivatives
WO2007122581A3 (en) Compositions and kits of phenylephrine
WO2008130953A3 (en) 2-imin0is0thiaz0le derivatives as cannabinoid receptor ligands
MY153763A (en) Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof
WO2006117211A3 (en) Urea derivatives methods for their manufacture and uses thereof
WO2007126900A3 (en) Antifungal agents
WO2007085629A3 (en) Use of hyaluronic acid as a carrier molecule for?different classes of therapeutic active agents
BRPI1011804A2 (en) pharmaceutical composition with improved solubility
WO2006077024A3 (en) 5-aminoindole derivatives
UA96759C2 (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
WO2008073863A3 (en) Preparation and utility of substituted allylamines
WO2008007153A3 (en) Antiviral compounds
WO2010013835A3 (en) Solid pharmaceutical composition
WO2008001204A3 (en) Transdermal compositions of pramipexole having enhanced permeation properties